EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
VitriVax is a formulation technology company that engineers innovative solutions to maximize global accessibility and utility of human vaccines.
No recent news for this company.
VitriVax Raises $17.25M Series B to Advance Thermostable Vaccine Technology
VitriVax Raises $17.25M Series B Led by Adjuvant Capital and RA Capital